<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Familial <z:e sem="disease" ids="C0005818" disease_type="Disease or Syndrome" abbrv="">platelet disorder</z:e> with a propensity to develop <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (FPD/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) is a rare <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> disease characterized by <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, <z:hpo ids='HP_0011869'>abnormal platelet function</z:hpo>, and a propensity to develop <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>So far, &gt; 20 affected families have been reported </plain></SENT>
<SENT sid="2" pm="."><plain>Recently, a second RUNX1 alteration has been reported; however, no additional molecular abnormalities have been found so far </plain></SENT>
<SENT sid="3" pm="."><plain>We identified an acquired CBL mutation and 11q-acquired <z:mp ids='MP_0008867'>uniparental disomy</z:mp> (11q-aUPD) in a patient with <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e>) secondary to FPD with RUNX1 mutation but not in the same patient during refractory cytopenia </plain></SENT>
<SENT sid="4" pm="."><plain>This finding suggests that alterations of the CBL gene and RUNX1 gene may cooperate in the pathogenesis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> in patients with FPD/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The presence of CBL mutations and 11q-aUPD was an important "second hit" that could be an indicator of leukemic transformation of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> in patients with FPD/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
</text></document>